| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4002748 | American Journal of Ophthalmology | 2012 | 7 Pages |
Abstract
Eyes with neovascular age-related macular degeneration experienced significant visual improvements on average when managed with intravitreal bevacizumab using a treat-and-extend regimen with fewer patient visits and injections along with lower costs compared with a fixed, monthly dosing regimen.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Gary Shienbaum, Omesh P. Gupta, Christopher Fecarotta, Avni H. Patel, Richard S. Kaiser, Carl D. Regillo,